Health Economics and Market Access for Orphan Drugs

Orphan drug development comes with high costs that pose challenges to market access. Health economics plays a pivotal role in assessing the value and cost-effectiveness of treatments. New models of pricing, reimbursement strategies, and health technology assessments (HTAs) help balance affordability and company sustainability. Patient assistance programs and partnerships with non-profits are essential for equitable access to life-saving treatments. Addressing economic and market challenges ensures that orphan drugs can benefit those who need them most.

 

    Related Conference of Health Economics and Market Access for Orphan Drugs

    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic
    June 29-30, 2026

    7th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 25-26, 2026

    18th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands

    Health Economics and Market Access for Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in